Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Scientific Reports|March 29, 2018
NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall SurvivalFoteinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, Anastasia E Kottorou, et al.
Scientific Reports|October 6, 2019
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC PatientsFoteinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, Anastasia E Kottorou, et al.
World Journal of Urology|November 13, 2012
PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?Iason Kyriazis, George C Kagadis, Panagiotis Kallidonis, et al.
International Journal of Hematology|November 6, 2016
A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in GreeceVasiliki Pappa, Achilles Anagnostopoulos, Eleni Bouronikou, et al.
Leukemia & Lymphoma|May 24, 2013
Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemiaSotirios Sachanas, Georgia Levidou, Maria K Angelopoulou, et al.
American Journal of Hematology|April 17, 2018
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study GroupSotirios G Papageorgiou, Diamantina Vasilatou, Christos K Kontos, et al.
Carcinogenesis|March 5, 2019
Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoterNikolaos I Kanellakis, Anastasios D Giannou, Mario A A Pepe, et al.
Hematological Oncology|August 22, 2018
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study GroupSotirios G Papageorgiou, Christos K Kontos, Ioannis Kotsianidis, et al.
Biomed Research International|June 3, 2014
Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significanceGeorgia Levidou, Sotirios Sachanas, Gerassimos A Pangalis, et al.
Leukemia & Lymphoma|November 15, 2018
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification systemPanagiotis T Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, et al.
Pageof 9